Enzyme Expression
Showing 1 - 25 of 8,003
Cutaneous Melanoma Trial in Paris (Blood sample, Cutaneous melanoma biopsy)
Recruiting
- Cutaneous Melanoma
- Blood sample
- Cutaneous melanoma biopsy
-
Paris, Ile De France, FranceDermatology department
Oct 24, 2022
Soluble B7-H3 as a Biomarker for Osteosarcoma
Recruiting
- Biomarker
- +3 more
- ELISA: enzyme-linked immunosorbent assay
-
Beijing, Beijing, ChinaPeking University People's Hospital
Jul 5, 2023
Proprotein Convertase Subtilisin Kexin 9 in Rheumatoid Arthritis
Recruiting
- PCSK9
- Enzyme-linked immunosorbent assay for PCSK9
-
Harbin, Heilongjiang, China
- +1 more
Dec 30, 2021
Angiotensin-converting Enzyme 2 Expression in Tonsils and
Withdrawn
- Adenoidectomy
- Tonsillectomy
- Storage of operating waste
-
Créteil, France
- +8 more
Jul 5, 2021
COVID-19, SARS-CoV-2, Furin Trial in India, Ukraine, United States
Recruiting
- COVID-19
- +4 more
-
Jacksonville, Florida
- +8 more
Aug 11, 2022
Type2 Diabetes Trial (vitamin D, vitamin D )
Enrolling by invitation
- Type2 Diabetes
- vitamin D
- vitamin D placebo
- (no location specified)
Jul 15, 2021
Genetic Susceptibility to Radiation-Induced Skin Reactions in
Completed
- Breast Cancer
- +6 more
- DNA analysis
- +14 more
-
Winston-Salem, North CarolinaWake Forest University Comprehensive Cancer Center
Sep 21, 2021
Study on AUNIP as a Novel Tumor Marker for Cervical Cancer
Not yet recruiting
- Cervical Cancer
- Detection of serum AUNIP expression
- (no location specified)
Nov 6, 2023
Irritable Bowel Syndrome (IBS) Trial in Nanjing (DAO supplement, Placebo)
Not yet recruiting
- Irritable Bowel Syndrome (IBS)
- DAO supplement
- Placebo
-
Nanjing, Jiangsu, ChinaZhenyu Zhang
Nov 15, 2023
Covid-19 Trial in Hellerup, Herlev (Discontinuation of ACEi/ARB, Continuation of ACEi/ARB)
Completed
- Covid-19
- Discontinuation of ACEi/ARB
- Continuation of ACEi/ARB
-
Hellerup, Capital Region Of Denmark, Denmark
- +1 more
Jan 17, 2023
TruGraf Liver Gene Expression Serial Test
Not yet recruiting
- Autoimmune Liver Disease
- +3 more
- TruGraf®
- (no location specified)
Sep 27, 2023
Oral Cancer, Oral Squamous Cell Carcinoma Trial in Fayoum (ELISA)
Recruiting
- Oral Cancer
- Oral Squamous Cell Carcinoma
- ELISA
-
Fayoum, EgyptFayoum University
Sep 8, 2023
Regional Anesthesia, General Anesthesia, Immune Function Trial in Homburg
Completed
- Regional Anesthesia
- +2 more
-
Homburg, Saarland, GermanySven O. Schneider, MD
May 10, 2022
Pheochromocytoma, Paraganglioma Trial in Philadelphia ([18F]FluorThanatrace ([18F]FTT))
Not yet recruiting
- Pheochromocytoma
- Paraganglioma
- [18F]FluorThanatrace ([18F]FTT)
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Dec 1, 2022
Cocaine Dependence, in Remission Trial in Rochester (AAV8-hCocH)
Recruiting
- Cocaine Dependence, in Remission
-
Rochester, MinnesotaMayo Clinic in Rochester
Oct 8, 2021
(CMS), UGT1A1 Genotype and Beta-glucuronidase Activity of
Recruiting
- Colorectal Neoplasms
-
Maastricht, Limburg, NetherlandsMaastricht UMC+
Jan 10, 2023
Role of Metabolic Enzymes in Non-Melanoma Skin Cancer
Completed
- Skin Cancer
- skin specimen
-
Irvine, California
- +1 more
Oct 28, 2022
Hypoxia-induced Autophagy in the Pathogenesis of MAP
Not yet recruiting
- Hypoxia
- +3 more
- HIF 1α and LC3B expression and MMP-9 level
- (no location specified)
Apr 5, 2023
Malaria Trial (Alpha-cypermethrin and PBO LLIN, Alpha-cypermethrin and Clorfenapyr LLIN, Alpha-cypermethrin only LLIN)
Not yet recruiting
- Malaria
- Alpha-cypermethrin and PBO LLIN
- +2 more
- (no location specified)
Mar 21, 2023
Implication of 5-HT7 Receptor in Inflammatory Mechanisms in
Not yet recruiting
- Healthy
- Multiple Sclerosis
- Blood sample
-
Orléans, FranceCHR Orléans
Feb 16, 2023
The Effect of RAAS Blockers on ACE2 Levels
Completed
- Renin-Angiotensin System
- ACE inhibitor ,angiotensin receptor blockers
-
Cairo, Select A State Or Province, EgyptAinshams University
Jun 10, 2022
Perioperative Sitagliptin Medication for Reduction of
Recruiting
- Systemic Inflammatory Response Syndrome
-
Münster, North Rhine-Westphalia, GermanyUniversity Hospital Münster
Feb 10, 2023